75 related articles for article (PubMed ID: 29520517)
41. A multicenter randomized controlled trial of tonsillectomy combined with steroid pulse therapy in patients with immunoglobulin A nephropathy.
Kawamura T; Yoshimura M; Miyazaki Y; Okamoto H; Kimura K; Hirano K; Matsushima M; Utsunomiya Y; Ogura M; Yokoo T; Okonogi H; Ishii T; Hamaguchi A; Ueda H; Furusu A; Horikoshi S; Suzuki Y; Shibata T; Yasuda T; Shirai S; Imasawa T; Kanozawa K; Wada A; Yamaji I; Miura N; Imai H; Kasai K; Soma J; Fujimoto S; Matsuo S; Tomino Y;
Nephrol Dial Transplant; 2014 Aug; 29(8):1546-53. PubMed ID: 24596084
[TBL] [Abstract][Full Text] [Related]
42. Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease.
Uemura O; Nagai T; Ishikura K; Ito S; Hataya H; Gotoh Y; Fujita N; Akioka Y; Kaneko T; Honda M
Clin Exp Nephrol; 2014 Aug; 18(4):626-33. PubMed ID: 24013764
[TBL] [Abstract][Full Text] [Related]
43. Is a legacy effect possible in IgA nephropathy?
Coppo R
Nephrol Dial Transplant; 2013 Jul; 28(7):1657-62. PubMed ID: 23539050
[TBL] [Abstract][Full Text] [Related]
44. Nationwide survey on current treatments for IgA nephropathy in Japan.
Matsuzaki K; Suzuki Y; Nakata J; Sakamoto N; Horikoshi S; Kawamura T; Matsuo S; Tomino Y
Clin Exp Nephrol; 2013 Dec; 17(6):827-33. PubMed ID: 23519367
[TBL] [Abstract][Full Text] [Related]
45. Long-term outcomes of IgA nephropathy presenting with minimal or no proteinuria.
Gutiérrez E; Zamora I; Ballarín JA; Arce Y; Jiménez S; Quereda C; Olea T; Martínez-Ara J; Segarra A; Bernis C; García A; Goicoechea M; García de Vinuesa S; Rojas-Rivera J; Praga M;
J Am Soc Nephrol; 2012 Oct; 23(10):1753-60. PubMed ID: 22956820
[TBL] [Abstract][Full Text] [Related]
46. Spontaneous remission in children with IgA nephropathy.
Shima Y; Nakanishi K; Hama T; Mukaiyama H; Togawa H; Sako M; Kaito H; Nozu K; Tanaka R; Iijima K; Yoshikawa N
Pediatr Nephrol; 2013 Jan; 28(1):71-6. PubMed ID: 22940909
[TBL] [Abstract][Full Text] [Related]
47. Significance of the duration of nephropathy for achieving clinical remission in patients with IgA nephropathy treated by tonsillectomy and steroid pulse therapy.
Ieiri N; Hotta O; Sato T; Taguma Y
Clin Exp Nephrol; 2012 Feb; 16(1):122-9. PubMed ID: 21912900
[TBL] [Abstract][Full Text] [Related]
48. Cyclosporine A vs. methylprednisolone for Henoch-Schönlein nephritis: a randomized trial.
Jauhola O; Ronkainen J; Autio-Harmainen H; Koskimies O; Ala-Houhala M; Arikoski P; Hölttä T; Jahnukainen T; Rajantie J; Ormälä T; Nuutinen M
Pediatr Nephrol; 2011 Dec; 26(12):2159-66. PubMed ID: 21626222
[TBL] [Abstract][Full Text] [Related]
49. Low-dose pulse methylprednisolone followed by short-term combination therapy and tonsillectomy for childhood IgA nephropathy.
Fujinaga S; Ohtomo Y; Hirano D; Nishizaki N; Someya T; Ohtsuka Y; Kaneko K; Shimizu T
Pediatr Nephrol; 2010 Mar; 25(3):563-4. PubMed ID: 19575240
[No Abstract] [Full Text] [Related]
50. Efficacy and safety of lisinopril for mild childhood IgA nephropathy: a pilot study.
Nakanishi K; Iijima K; Ishikura K; Hataya H; Awazu M; Sako M; Honda M; Yoshikawa N;
Pediatr Nephrol; 2009 Apr; 24(4):845-9. PubMed ID: 18825420
[TBL] [Abstract][Full Text] [Related]
51. Clinical course and prognostic factors of clinical early IgA nephropathy.
Shen P; He L; Huang D
Neth J Med; 2008 Jun; 66(6):242-7. PubMed ID: 18689907
[TBL] [Abstract][Full Text] [Related]
52. [Guidelines for the treatment of childhood IgA nephropathy].
Yoshikawa N; Igarashi T; Ishikura K; Kaku Y; Nakazato H; Kamei K; Kawamura T; Nakamura H; Yamamoto Y; Nakanishi K; Sako M
Nihon Jinzo Gakkai Shi; 2008; 50(1):31-41. PubMed ID: 18318242
[No Abstract] [Full Text] [Related]
53. Steroid treatment for severe childhood IgA nephropathy: a randomized, controlled trial.
Yoshikawa N; Honda M; Iijima K; Awazu M; Hattori S; Nakanishi K; Ito H;
Clin J Am Soc Nephrol; 2006 May; 1(3):511-7. PubMed ID: 17699253
[TBL] [Abstract][Full Text] [Related]
54. Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy.
Hotta O; Miyazaki M; Furuta T; Tomioka S; Chiba S; Horigome I; Abe K; Taguma Y
Am J Kidney Dis; 2001 Oct; 38(4):736-43. PubMed ID: 11576876
[TBL] [Abstract][Full Text] [Related]
55. The natural history of immunoglobulin a nephropathy among patients with hematuria and minimal proteinuria.
Szeto CC; Lai FM; To KF; Wong TY; Chow KM; Choi PC; Lui SF; Li PK
Am J Med; 2001 Apr; 110(6):434-7. PubMed ID: 11331053
[TBL] [Abstract][Full Text] [Related]
56. Characterization of early IgA nephropathy.
Lai FM; Szeto CC; Choi PC; Li PK; Chan AW; Tang NL; Lui SF; Wang AY; To KF
Am J Kidney Dis; 2000 Oct; 36(4):703-8. PubMed ID: 11007671
[TBL] [Abstract][Full Text] [Related]
57. A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. The Japanese Pediatric IgA Nephropathy Treatment Study Group.
Yoshikawa N; Ito H; Sakai T; Takekoshi Y; Honda M; Awazu M; Ito K; Iitaka K; Koitabashi Y; Yamaoka K; Nakagawa K; Nakamura H; Matsuyama S; Seino Y; Takeda N; Hattori S; Ninomiya M
J Am Soc Nephrol; 1999 Jan; 10(1):101-9. PubMed ID: 9890315
[TBL] [Abstract][Full Text] [Related]
58. Initial treatment with pulse methylprednisolone followed by short-term prednisolone and tonsillectomy for childhood IgA nephropathy.
Yamada A; Fujinaga S; Sakuraya K; Satoshi A; Hirano D
Clin Exp Nephrol; 2018 Oct; 22(5):1143-1149. PubMed ID: 29520517
[TBL] [Abstract][Full Text] [Related]
59. Treatment of IgA nephropathy: corticosteroids, tonsillectomy, and mycophenolate mofetil.
Kawamura T
Contrib Nephrol; 2007; 157():37-43. PubMed ID: 17495435
[TBL] [Abstract][Full Text] [Related]
60. Tonsillectomy combined with steroid pulse therapy induces clinical remission of IgA nephropathy.
Komatsu H; Fujimoto S
Adv Otorhinolaryngol; 2011; 72():57-9. PubMed ID: 21865690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
